Definitions, End Points, and Clinical Trial Designs for Bladder Cancer

Healthcare3/18/2024 10:00 PM

Go to Registration Page

Description

Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations from the Society for Immunotherapy of Cancer & the International Bladder Cancer Group. Join the webinar on March 18, 2024, from 4-5 p.m. CST to discuss the publication in-depth with experts.

Comments

Rate This Webinar

community rating (0 votes): 
Rate or Review This Webinar

Publisher

Society for Immunotherapy of Cancer (SITC)

Society for Immunotherapy of Cancer (SITC)

The Society for Immunotherapy of Cancer (SITC) aims to improve cancer patient outcomes by advancing the science, development, and application of cancer immunology and immunotherapy. SITC works towards making cancer immunotherapy a standard of care and bringing the word 'cure' to reality for cancer patients everywhere.